144 related articles for article (PubMed ID: 37582570)
1. Application of serum gastric function markers and digestive tumor indices to the diagnosis of early gastric cancer and precancerous lesions.
Yanan Z; Juan W; Jun W; Xin M; Kejian W; Fangyu W
Saudi Med J; 2023 Aug; 44(8):795-800. PubMed ID: 37582570
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic Value of Serum Pepsinogen Ⅰ/Pepsinogen Ⅱ Combined with Tumor Markers for
Wang SS; Guo ZP; Zhao XY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):186-191. PubMed ID: 36647665
[TBL] [Abstract][Full Text] [Related]
3. Serum gastrin and the pepsinogen I/II ratio as markers for diagnosis of premalignant gastric lesions.
Shafaghi A; Mansour-Ghanaei F; Joukar F; Sharafkhah M; Mesbah A; Askari K; Geranmayeh S; Mehrvarz A; Souti F; Sokhanvar H; Fakhrieh S; Aminian K; Yousefi-Mashhour M; Khosh-Sorur M; Rasoulian J
Asian Pac J Cancer Prev; 2013; 14(6):3931-6. PubMed ID: 23886209
[TBL] [Abstract][Full Text] [Related]
4. Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions: a longitudinal study.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Long Q; Flanders WD; Bostick RM; Yuan Y
Int J Cancer; 2015 Jan; 136(2):425-34. PubMed ID: 24895149
[TBL] [Abstract][Full Text] [Related]
5. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
Wang X; Zhang Q; Han F; Wu Y
Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
[No Abstract] [Full Text] [Related]
6. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
7. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of MRI-DWI signal intensity value combined with serum PGI, PGII and CA199 in early gastric cancer.
Li M; Zheng G; Yu L; Tan LL; Li X; Li MJ; Li C; Li S; Liang J; Zhong Z; Li ZM
Cell Mol Biol (Noisy-le-grand); 2021 Aug; 67(2):95-100. PubMed ID: 34817333
[TBL] [Abstract][Full Text] [Related]
9. Serum CA724 has no diagnostic value for gastrointestinal tumors.
Cao H; Zhu L; Li L; Wang W; Niu X
Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
[TBL] [Abstract][Full Text] [Related]
10. The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment.
Li F; Li S; Wei L; Liang X; Zhang H; Liu J
Biomarkers; 2013 Nov; 18(7):632-7. PubMed ID: 24066812
[TBL] [Abstract][Full Text] [Related]
11. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
[TBL] [Abstract][Full Text] [Related]
12. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
Wang R; Zuo CL; Zhang R; Zhu LM
World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
[TBL] [Abstract][Full Text] [Related]
13. The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.
Yu G; Wang GX; Wang HG; Mo FF; Tang BB
Neoplasma; 2019 Jul; 66(4):637-640. PubMed ID: 31058531
[TBL] [Abstract][Full Text] [Related]
14. Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.
Chen XZ; Zhang WH; Yang K; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
Tumour Biol; 2014 Sep; 35(9):9015-22. PubMed ID: 24906604
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Value of Helicobacter pylori Test in Combination with the Determination of Plasma Propepsin and Gastrin 17 in Screening the Precancerous Status of Gastric Cancer.
Xiao M; Zhang Z; Liao G; Liu M; Chen X
Cell Mol Biol (Noisy-le-grand); 2022 Aug; 68(8):110-115. PubMed ID: 36800825
[TBL] [Abstract][Full Text] [Related]
16. [Expression and significance of trefoil factor 1 protein and serum pepsinogen in benign and malignant gastric ulcers].
Yang J; Li CX; Dai YY; Peng F; Weng XM; Ji MX
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(22):1540-3. PubMed ID: 22944057
[TBL] [Abstract][Full Text] [Related]
17. Application of serum pepsinogen and carbohydrate antigen 72-4 (CA72-4) combined with gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer.
Lin Z; Bian H; Chen C; Chen W; Li Q
J Gastrointest Oncol; 2021 Jun; 12(3):1042-1048. PubMed ID: 34295555
[TBL] [Abstract][Full Text] [Related]
18. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
19. The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China.
Shen H; Xiong K; Wu X; Cheng S; Lou Q; Jin H; Zhang X
Gastroenterol Res Pract; 2021; 2021():6894248. PubMed ID: 33936196
[TBL] [Abstract][Full Text] [Related]
20. Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study.
Li X; Li S; Zhang Z; Huang D
PeerJ; 2022; 10():e13488. PubMed ID: 35611170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]